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Results: 40 patients were recruited (mean age 49.7;
62% female). Compliance with daily diary completion was
97%. Symptom scores remained stable for 14 days pretreat-
ment and symptom score fell by 80% post GSV closure. ES
(mean change/SD) and correlations with other instru-
ments are shown in Table.
Conclusions: VVSymQ™ is a simple patient-centered
measure that can be administered daily via a PDA with very
high compliance. It is sensitive to clinically important
symptom improvements following GSV closure and corre-
lates with existing instruments.
ES and correlation between instruments pre and post
GSV closure
Table.
VVSymQ PA-V3 VCSS
VEINES-
QoL
CIVIQ-
20
Effect size (ES) 2.0 (paper) 1.6
(electronic)
1.5 3.4 1.8 1.2
Correlation
pre-GSV
closure
– 0.318a NS 0.727c 0.518c
Correlation 8
week post-
GSV closure
– NS 0.456b 0.755c 0.587c
aP.05;
bP.01;
cP.001; NSnot significant
Author Disclosures: G. Bate: Nothing to disclose; A.
Bradbury: Nothing to disclose; T. King: BTG Interna-
tional Inc.,Employment (full or part-time); E. Thomas:
BTG International Inc., Employment (full or part-time);
D. Wright: BTG International Inc.,Employment (full or
part-time)
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Jack L. Eidson1, Deepa Raghunathan1, Marvin D. Atkins1,
Clifford J. Buckley1, Ruth L. Bush2, William T. Bohan-
non1. 1Vascular Surgery, Scott and White, Temple, TX;
2Central Texas VA Hospital, Temple, TX
Objectives: Endovenous ablation of the great and
small saphenous veins has become the standard surgical
therapy for the treatment of chronic venous insufficiency
(CVI). Vein recanalization following radiofrequency abla-
tion (RFA) has been described. This study reviewed the
incidence of and risk factors for developing recanalization
after successful ablation.
Methods: This two-center retrospective study re-
viewed 249 limbs that underwent RFA of either the great
(GSV) or small saphenous vein (SSV) over a three-year
period, and for which an intermediate duplex ultrasound
was available. All cases of saphenous recanalization (N16,
6.4%), were identified and the associated patient data,
including comorbidities and need for additional interven-
tions, were analyzed.
Results: Seventeen limbs demonstrated either seg-
mental (9, 53%) or complete (8, 47%) recanalization of
the GSV after initial successful ablation. Recanalization
was associated with higher rate of symptom recurrence
(41% v 21%, RR 2.75, 95% CI, 0.99-7.6) and need for a
second vein procedure in the affected limb (35% v 12%,
RR 3.96, 95% CI 1.3-11.7). Two GSVs required a
second endovenous ablation for persistent venous ulcers.
Concomitant diabetes, hyperlipidemia, anticoagulation
use, antiplatelet use, presence of deep reflux, or tobacco
use did not increase the risk of recanalization. Compar-
atively, patients with GSV recanalization had a longer
mean follow-up (63.3 v. 41.6 weeks) but no difference in
disease severity (C4, 35% v. 17%; C5, 18% v. 15%; C6, 6%
v. 8%, NS).
Conclusions: GSV recanalization following RFA for
the treatment of CVI appears to be a sporadic phenomenon
without clearly associated risk factors. Recanalization, al-
though often involving an isolated segment of the great
saphenous vein, is associated with a two-fold increase in
symptom recurrence and the need for interval vein proce-
dures. Follow-up ultrasound interrogation is recom-
mended especially in patients with persistent or recurrent
symptoms or ulceration.
Author Disclosures: M. D. Atkins: Nothing to disclose;
W. T. Bohannon: Nothing to disclose; C. J. Buckley:
Nothing to disclose; R. L. Bush: Nothing to disclose; J. L.
Eidson: Nothing to disclose; D. Raghunathan: Nothing
to disclose.
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Calf Deep Vein Thrombosis: Current Trends in Man-
agement
Arjun Jayaraj, Brenda Zierler, MarkMeissner. University of
Washington, Seattle, WA
Objectives: Deep vein thrombosis (DVT) involving
calf veins is relatively common condition with an incidence
of almost 2% in the general population. Despite this high
incidence there is lack of consensus regarding appropriate
management of the condition borne primarily from paucity
of evidence. Our objective as a prelude to a larger random-
ized trial was to review current management practices by
means of a national survey.
Methods: The survey was conducted among vascular
specialists who routinely manage patients with calf DVT.
This was done by means of a 19 point questionnaire. The
110 responses accrued were collated and analyzed to ascer-
tain practice patterns.
Results: Of the 110 practitioners 68 (62%) were Vas-
cular Surgeons. Amongst the responders, while 93 (85%)
would anticoagulate for axial calf vein DVT, only 60 (55%)
would anticoagulate for muscular calf vein DVT. Of those
practitioners anticoagulating for calf DVT 60% would fol-
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low patients with duplex surveillance compared to 70% in
the no anticoagulation group. There was significant vari-
ation in timing and duration of duplex surveillance for
those not anticoagulated (Day 3 to day 14). Among
those who used duplex surveillance only 47% had a
protocol for surveillance. Safety of anticoagulation, risk
of development of post thrombotic syndrome and qual-
ity of life were the key criteria that factored into prescrip-
tion of anticoagulation. Majority of respondents felt that
use of anticoagulation could prevent progression of calf
vein DVT. 79% of respondents felt that appropriateness
of anticoagulation for calf DVT needed to be addressed
with a well designed trial.
Conclusions: Currently there does not appear to be
consensus regarding the role of anticoagulation following
diagnosis of calf deep vein thrombosis. Additionally, the
ideal pattern of surveillance following diagnosis of DVT
also needs to be clarified. These are questions best answered
by a well designed randomized trial.
Author Disclosures: A. Jayaraj: Nothing to disclose; M.
Meissner: Nothing to disclose; B. Zierler: Nothing to
disclose.
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Trends in Outpatient Treatment of Vascular Diseases
Michael Yen1, Natalia N. Egorova1, Alan J. Moskowitz1,
Eugene A. Sosunov2, James F. McKinsey2, Roman Now-
ygrod2. 1Mount Sinai School of Medicine, New York, NY;
2Columbia University, New York Presbyterian Hospital,
New York, NY
Objectives: Recent trends for increase in inpatient
vascular surgery (IP) are well documented. In this study
we review utilization and procedural shifts for outpatient
vascular procedures (OP) for which there are little data.
Methods: The National Survey of Ambulatory Surgery
database was used to determine nationwide rates of OP
for years 1994-1996, and 2006; the National Inpatient
Sample was used for IP. States CA, FL, NY and MD
provided both IP and OP data, and were used as a
representative sample of the nation for 2006-2009. CPT
and ICD9 codes were divided into procedure groups and
used to query the databases. Trends were analyzed using
interrupted time series.
Results: Between 1994 and 2009 the rate of OP
increased 250%, from 93.3 to 326.9 per 100,000 capita.
Aging population accounted for 39% of the increase.
Growth in OP outpaced IP, accounting for 15.8% of all
interventions in 1994 and 32.3% in 2009. Patients 65
years and older had the greatest increase, and men had
higher rates than women. Of the procedure groups,
revascularization, imaging and arteriovenous access had
the largest percent increase; rates of venous , skin graft
and minor amputation procedures were stable (Table).
Conclusions: Vascular surgeries are increasingly per-
formed as outpatient operations, both in absolute number
and as a percent of the total. Possible causes include an
increase in the prevalence of relevant risk factors, newer
technologies, proliferation of freestanding surgical units
and reimbursement policies.
Table. Trends in the utilization of specific outpatient
surgery groups
NSAS No data
post-2006 Combined states
Percent
change
Procedures per
100000
Procedures per
100000
1994 2006 2006 2009
Revascularization 7.75 36.28 38.79 50.06 545.58%
AV access 11.11 44.48 46.85 52.97 376.78%
Imaging 26.73 86.44 75.88 91.50 242.37%
Venous
procedures
17.99 32.46 26.64 26.32 46.29%
Minor
amputation
2.85 7.14 3.40 3.63 27.18%
Skin graft 2.90 3.67 2.52 2.80 -3.68%
Author Disclosures: N. N. Egorova: Nothing to disclose;
J. F. McKinsey: Nothing to disclose; A. J. Moskowitz:
Nothing to disclose; R. Nowygrod: Nothing to disclose;
E. A. Sosunov: Nothing to disclose; M. Yen: Nothing to
disclose.
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Surgical Managment of Infected Femoral Artery Pseu-
daneursms: A Contemporary Series
Sherene Shalhub, Benjamin W. Starnes, Brandon T. Gar-
land, Anthony J. Pirot, Nam T. Tran. Vascular Surgery
Division, University of Washington, Seattle, WA
Objectives: Infected femoral artery pseudoaneurysms
(IFAPs) are a significant surgical challenge and can lead to
life-threatening hemorrhage or limb loss in a primarily
young population.
Methods: A retrospective review of patients who pre-
sented with IFAPs between 1997 and 2010. Demograph-
ics, initial presentation, pre-operative imaging, surgical in-
tervention, and outcome data were recorded.
Results: Fifty cases were treated during the study pe-
riod. The majority were male (72%), with median age of 37
years old (range 21-63). Black tar heroin injection was the
most common etiology (84%), followed by access site pseu-
doaneurysms (10%). Common femoral artery ligation was
performed in 42 cases (84%) with preservation of the fem-
oral bifurcation in 28 cases (56%). Vascular control was
accomplished by proximal occlusion of the ipsilateral
external iliac artery via a retroperitoneal incision in 24%
of the cases or by selective cannulation of the ipsilateral
external iliac artery from a contralateral percutaneous
common femoral artery approach and placement of a
compliant occlusion balloon (14%). In the remainder of
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